Literature DB >> 6692368

Involvement of histamine in growth of mouse and rat tumors: antitumoral properties of monofluoromethylhistidine, an enzyme-activated irreversible inhibitor of histidine decarboxylase.

J Bartholeyns, M Bouclier.   

Abstract

The present study suggests that newly synthesized histamine is involved in the development of some animal tumors (e.g., Lewis lung carcinoma in mice and Morris hepatoma in rats). A marked induction of histidine decarboxylase (HDC) and an increase in the histamine concentration were observed in the tumors approximately 1 week after inoculation, and there were parallel increases in ornithine decarboxylase activity and the concentrations of polyamines. The H2 receptor antagonist, cimetidine, significantly reduced tumor growth in the animal models while the H1 receptor antagonist, dexchlorpheniramine, had no effect, suggesting that histamine could act via H2 receptor sites. Extensive depletion of tumor histamine induced by local injection of Compound 48/80 did not result in a significant cytostatic effect. Monofluoromethylhistidine (MFMH), an enzyme-activated irreversible inhibitor of HDC, retarded the growth of hepatoma tissue culture cells grown in culture, and when infused s.c. at 60 mg/kg/day it greatly inhibited the development of tumors induced i.m. by hepatoma tissue culture cells in Buffalo rats. MFMH also had pronounced antitumoral effects on EMT6 sarcomas and Lewis lung carcinomas in mice, which were associated with inhibition of HDC and depletion of the histamine content of the tumors. These cytostatic effects were clearly enhanced when MFMH was combined in therapy with the specific ornithine decarboxylase inhibitor, DL-alpha-difluoromethylornithine. The antitumoral effects of the combination were associated with marked decreases in the tumor histamine and putrescine contents. It is proposed that nascent histamine, like newly synthesized putrescine and spermidine, plays a role in the rapid proliferation of animal tumors. Inhibition of HDC by essentially nontoxic drugs such as MFMH could represent a novel approach to the control of neoplastic growth.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6692368

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

Review 1.  Biological effects of histamine: an overview.

Authors:  F L Pearce
Journal:  Agents Actions       Date:  1991-05

2.  Histamine and histidine decarboxylase are correlated with mucosal repair in rat small intestine after ischemia-reperfusion.

Authors:  K Fujimoto; I Imamura; D N Granger; H Wada; T Sakata; P Tso
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

3.  Effect of histamine on the development of astroglial cells in culture.

Authors:  J Rodriguez; J Moran; I Blanco; A J Patel
Journal:  Neurochem Res       Date:  1989-07       Impact factor: 3.996

4.  Causal relationship between a tumour growth and the changes in histamine metabolism in tissues of sarcoma-bearing rat.

Authors:  D Kierska; K Sasiak; T Biegański; C Maśliński
Journal:  Agents Actions       Date:  1987-04

5.  Stimulation of histamine synthesis from tumour cells by concanavalin A and A23187.

Authors:  H Nolte; P Stahl Skov; H Loft
Journal:  Agents Actions       Date:  1987-04

6.  Growing tumors induce hypersensitivity to endotoxin and tumor necrosis factor.

Authors:  J Bartholeyns; M Freudenberg; C Galanos
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

7.  Chlorpheniramine inhibits the synthesis of ornithine decarboxylase and the proliferation of human breast cancer cell lines.

Authors:  M A Medina; R García de Veas; P Morata; J Lozano; F Sánchez-Jiménez
Journal:  Breast Cancer Res Treat       Date:  1995-08       Impact factor: 4.872

8.  Changes in histamine synthesis, tissue content and catabolism in human breast cancer.

Authors:  M Garcia-Caballero; E Neugebauer; F Rodriguez; I Nuñez de Castro; A Heredia; E Oosting; C Vara Thorbeck
Journal:  Agents Actions       Date:  1989-04

9.  Simultaneous fluorometric determination of intracellular polyamines separated by reversed-phase high-performance liquid chromatography.

Authors:  J M Matés; J Márquez; M García-Caballero; I Núñez de Castro; F Sánchez-Jiménez
Journal:  Agents Actions       Date:  1992-05

10.  In vivo and in vitro anti-tumour activity of dimaprit.

Authors:  A Fray; C Burtin; P Scheinmann; G Lespinats; P Canu
Journal:  Agents Actions       Date:  1985-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.